Randomized, Double-blind, Crossover, Pharmacokinetic (PK) and Glucodynamic (GD) Study of Continuous Subcutaneous Insulin Infusion (CSII) in Participants With Type 1 Diabetes Mellitus (T1DM)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG

Insulin aspart

DRUG

Recombinant human hyaluronidase PH20 (rHuPH20)

Trial Locations (1)

Profil Institute for Clinical Research, Chula Vista